Antibodies specific for hyperphosphorylated tau and methods of use thereof
Номер патента: MY197836A
Опубликовано: 20-07-2023
Автор(ы): Ayodeji Abdur-Rasheed Asuni, Christiane VOLBRACHT, Jan Torleif Pedersen, Juhl Karsten, Justus Claus Alfred DAECHSEL, Kristian Kj?Rgaard, Lars ?Stergaard Pedersen, LAURENT David, Lena Tagmose, Lone HELBO, Marigo Mauro, Nina Helen ROSENQVIST, S?Ren Christensen, Thomas Jensen
Принадлежит: H Lundbeck AS
Опубликовано: 20-07-2023
Автор(ы): Ayodeji Abdur-Rasheed Asuni, Christiane VOLBRACHT, Jan Torleif Pedersen, Juhl Karsten, Justus Claus Alfred DAECHSEL, Kristian Kj?Rgaard, Lars ?Stergaard Pedersen, LAURENT David, Lena Tagmose, Lone HELBO, Marigo Mauro, Nina Helen ROSENQVIST, S?Ren Christensen, Thomas Jensen
Принадлежит: H Lundbeck AS
Реферат: The present invention relates to a class of monoclonal antibody that specifically binds the phosphorylated serine 396 residue on pathological hyperphosphorylated (PHF) tau (pS396) with improved affinity, as well as to methods of using these molecules and their tau binding fragments in the treatment of Alzheimer?s disease and other tauopathies.
Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof
Номер патента: US09932637B2. Автор: Koustubh Ranade,Peter Shaw,Zenta Tsuchihashi,Lynn Marie Ploughman,Olga Iakoubova,James J. Devlin,Kim E. Zerba,Todd Kirchgessner. Владелец: Celera Corp. Дата публикации: 2018-04-03.